Please find attached Intimation for analyst/investor Earning conference call on the Audited Financial Results of the Company for the financial year ended March 31, 2026
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Thyrocare Technologies has issued a formal invite for an earnings conference call scheduled for May 12, 2026 at 9:00 AM IST to discuss the company's audited financial results for Q4FY26 and the full financial year ended March 31, 2026. The call will feature senior management including Chairman/MD/CEO Rahul Guha, CCO Rajdeep Panwar, COO Dr. Ramesh Kinha, CFO Vikram Gupta, and Manager-Strategy & IR Preet Joshi. The filing is made under SEBI Regulation 30 as a routine disclosure requirement. No financial figures or business updates are provided in this announcement.
This is a standard regulatory filing announcing an upcoming earnings call. No new material information is disclosed — the actual results and any accompanying commentary will be shared during the May 12 call. Shareholders should note the date to participate or review the webcast.